Titre : Noyaux gris centraux

Noyaux gris centraux : Questions médicales fréquentes

Termes MeSH sélectionnés :

Implementation Science
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Noyaux gris centraux : Questions médicales les plus fréquentes", "headline": "Noyaux gris centraux : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Noyaux gris centraux : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-05-25", "dateModified": "2025-02-19", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Noyaux gris centraux" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Cerveau", "url": "https://questionsmedicales.fr/mesh/D054022", "about": { "@type": "MedicalCondition", "name": "Cerveau", "code": { "@type": "MedicalCode", "code": "D054022", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A08.186.211.200.885.287" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Amygdale (système limbique)", "alternateName": "Amygdala", "url": "https://questionsmedicales.fr/mesh/D000679", "about": { "@type": "MedicalCondition", "name": "Amygdale (système limbique)", "code": { "@type": "MedicalCode", "code": "D000679", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A08.186.211.200.885.287.249.152" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Groupe nucléaire basolatéral", "alternateName": "Basolateral Nuclear Complex", "url": "https://questionsmedicales.fr/mesh/D066272", "about": { "@type": "MedicalCondition", "name": "Groupe nucléaire basolatéral", "code": { "@type": "MedicalCode", "code": "D066272", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A08.186.211.200.885.287.249.152.500" } } }, { "@type": "MedicalWebPage", "name": "Noyau central de l'amygdale", "alternateName": "Central Amygdaloid Nucleus", "url": "https://questionsmedicales.fr/mesh/D066274", "about": { "@type": "MedicalCondition", "name": "Noyau central de l'amygdale", "code": { "@type": "MedicalCode", "code": "D066274", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A08.186.211.200.885.287.249.152.750" } } }, { "@type": "MedicalWebPage", "name": "Groupe nucléaire cortico-médial", "alternateName": "Corticomedial Nuclear Complex", "url": "https://questionsmedicales.fr/mesh/D066276", "about": { "@type": "MedicalCondition", "name": "Groupe nucléaire cortico-médial", "code": { "@type": "MedicalCode", "code": "D066276", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A08.186.211.200.885.287.249.152.875" } } } ] }, { "@type": "MedicalWebPage", "name": "Claustrum", "alternateName": "Claustrum", "url": "https://questionsmedicales.fr/mesh/D000079482", "about": { "@type": "MedicalCondition", "name": "Claustrum", "code": { "@type": "MedicalCode", "code": "D000079482", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A08.186.211.200.885.287.249.320" } } }, { "@type": "MedicalWebPage", "name": "Corps strié", "alternateName": "Corpus Striatum", "url": "https://questionsmedicales.fr/mesh/D003342", "about": { "@type": "MedicalCondition", "name": "Corps strié", "code": { "@type": "MedicalCode", "code": "D003342", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A08.186.211.200.885.287.249.487" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Globus pallidus", "alternateName": "Globus Pallidus", "url": "https://questionsmedicales.fr/mesh/D005917", "about": { "@type": "MedicalCondition", "name": "Globus pallidus", "code": { "@type": "MedicalCode", "code": "D005917", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A08.186.211.200.885.287.249.487.397" } } }, { "@type": "MedicalWebPage", "name": "Néostriatum", "alternateName": "Neostriatum", "url": "https://questionsmedicales.fr/mesh/D017072", "about": { "@type": "MedicalCondition", "name": "Néostriatum", "code": { "@type": "MedicalCode", "code": "D017072", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A08.186.211.200.885.287.249.487.550" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Noyau caudé", "alternateName": "Caudate Nucleus", "url": "https://questionsmedicales.fr/mesh/D002421", "about": { "@type": "MedicalCondition", "name": "Noyau caudé", "code": { "@type": "MedicalCode", "code": "D002421", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A08.186.211.200.885.287.249.487.550.184" } } }, { "@type": "MedicalWebPage", "name": "Putamen", "alternateName": "Putamen", "url": "https://questionsmedicales.fr/mesh/D011699", "about": { "@type": "MedicalCondition", "name": "Putamen", "code": { "@type": "MedicalCode", "code": "D011699", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A08.186.211.200.885.287.249.487.550.784" } } } ] }, { "@type": "MedicalWebPage", "name": "Noyau caudé", "alternateName": "Caudate Nucleus", "url": "https://questionsmedicales.fr/mesh/D002421", "about": { "@type": "MedicalCondition", "name": "Noyau caudé", "code": { "@type": "MedicalCode", "code": "D002421", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A08.186.211.200.885.287.249.487.550.184" } } }, { "@type": "MedicalWebPage", "name": "Putamen", "alternateName": "Putamen", "url": "https://questionsmedicales.fr/mesh/D011699", "about": { "@type": "MedicalCondition", "name": "Putamen", "code": { "@type": "MedicalCode", "code": "D011699", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A08.186.211.200.885.287.249.487.550.784" } } }, { "@type": "MedicalWebPage", "name": "Striatum ventral", "alternateName": "Ventral Striatum", "url": "https://questionsmedicales.fr/mesh/D066328", "about": { "@type": "MedicalCondition", "name": "Striatum ventral", "code": { "@type": "MedicalCode", "code": "D066328", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A08.186.211.200.885.287.249.487.775" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Noyau accumbens", "alternateName": "Nucleus Accumbens", "url": "https://questionsmedicales.fr/mesh/D009714", "about": { "@type": "MedicalCondition", "name": "Noyau accumbens", "code": { "@type": "MedicalCode", "code": "D009714", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A08.186.211.200.885.287.249.487.775.500" } } } ] }, { "@type": "MedicalWebPage", "name": "Noyau accumbens", "alternateName": "Nucleus Accumbens", "url": "https://questionsmedicales.fr/mesh/D009714", "about": { "@type": "MedicalCondition", "name": "Noyau accumbens", "code": { "@type": "MedicalCode", "code": "D009714", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A08.186.211.200.885.287.249.487.775.500" } } } ] }, { "@type": "MedicalWebPage", "name": "Substance innominée", "alternateName": "Substantia Innominata", "url": "https://questionsmedicales.fr/mesh/D013377", "about": { "@type": "MedicalCondition", "name": "Substance innominée", "code": { "@type": "MedicalCode", "code": "D013377", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A08.186.211.200.885.287.249.880" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Noyau basal de Meynert", "alternateName": "Basal Nucleus of Meynert", "url": "https://questionsmedicales.fr/mesh/D020532", "about": { "@type": "MedicalCondition", "name": "Noyau basal de Meynert", "code": { "@type": "MedicalCode", "code": "D020532", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A08.186.211.200.885.287.249.880.100" } } } ] } ], "about": { "@type": "MedicalCondition", "name": "Noyaux gris centraux", "alternateName": "Basal Ganglia", "code": { "@type": "MedicalCode", "code": "D001479", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "None None", "url": "https://questionsmedicales.fr/author/None%20None", "affiliation": { "@type": "Organization", "name": "" } }, { "@type": "Person", "name": "Clara Rodriguez-Sabate", "url": "https://questionsmedicales.fr/author/Clara%20Rodriguez-Sabate", "affiliation": { "@type": "Organization", "name": "Laboratory of Neurobiology and Experimental Neurology, Department of Basic Medical Sciences, Faculty of Medicine, University of La Laguna, Tenerife, Canary Islands, Spain." } }, { "@type": "Person", "name": "Ingrid Morales", "url": "https://questionsmedicales.fr/author/Ingrid%20Morales", "affiliation": { "@type": "Organization", "name": "Laboratory of Neurobiology and Experimental Neurology, Department of Basic Medical Sciences, Faculty of Medicine, University of La Laguna, Tenerife, Canary Islands, Spain." } }, { "@type": "Person", "name": "Manuel Rodriguez", "url": "https://questionsmedicales.fr/author/Manuel%20Rodriguez", "affiliation": { "@type": "Organization", "name": "Laboratory of Neurobiology and Experimental Neurology, Department of Basic Medical Sciences, Faculty of Medicine, University of La Laguna, Tenerife, Canary Islands, Spain. mrdiaz@ull.edu.es." } }, { "@type": "Person", "name": "Sachin Manjunath", "url": "https://questionsmedicales.fr/author/Sachin%20Manjunath", "affiliation": { "@type": "Organization", "name": "Aster Medcity, Kochi, India." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Advancing health equity through implementation science: Identifying and examining measures of the outer setting.", "datePublished": "2023-07-17", "url": "https://questionsmedicales.fr/article/37473542", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.socscimed.2023.116095" } }, { "@type": "ScholarlyArticle", "name": "Implementation Science and Pediatric Diabetes: A Scoping Review of the State of the Literature and Recommendations for Future Research.", "datePublished": "2024-10-29", "url": "https://questionsmedicales.fr/article/39470899", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s11892-024-01561-3" } }, { "@type": "ScholarlyArticle", "name": "Economic evaluation of implementation science outcomes in low- and middle-income countries: a scoping review.", "datePublished": "2022-11-16", "url": "https://questionsmedicales.fr/article/36384807", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s13012-022-01248-x" } }, { "@type": "ScholarlyArticle", "name": "Implementation of prediction models in the emergency department from an implementation science perspective-Determinants, outcomes and real-world impact: A scoping review protocol.", "datePublished": "2022-05-12", "url": "https://questionsmedicales.fr/article/35551537", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1371/journal.pone.0267965" } }, { "@type": "ScholarlyArticle", "name": "Generative AI in healthcare: an implementation science informed translational path on application, integration and governance.", "datePublished": "2024-03-15", "url": "https://questionsmedicales.fr/article/38491544", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s13012-024-01357-9" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Système nerveux", "item": "https://questionsmedicales.fr/mesh/D009420" }, { "@type": "ListItem", "position": 3, "name": "Système nerveux central", "item": "https://questionsmedicales.fr/mesh/D002490" }, { "@type": "ListItem", "position": 4, "name": "Encéphale", "item": "https://questionsmedicales.fr/mesh/D001921" }, { "@type": "ListItem", "position": 5, "name": "Prosencéphale", "item": "https://questionsmedicales.fr/mesh/D016548" }, { "@type": "ListItem", "position": 6, "name": "Télencéphale", "item": "https://questionsmedicales.fr/mesh/D013687" }, { "@type": "ListItem", "position": 7, "name": "Cerveau", "item": "https://questionsmedicales.fr/mesh/D054022" }, { "@type": "ListItem", "position": 8, "name": "Noyaux gris centraux", "item": "https://questionsmedicales.fr/mesh/D001479" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Noyaux gris centraux - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Noyaux gris centraux", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-11", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Noyaux gris centraux", "description": "Comment diagnostiquer une dysfonction des noyaux gris centraux ?\nQuels tests sont utilisés pour évaluer les noyaux gris centraux ?\nQuels signes cliniques indiquent une atteinte des noyaux gris centraux ?\nLes tests génétiques sont-ils utiles pour le diagnostic ?\nQuelle est l'importance de l'historique médical dans le diagnostic ?", "url": "https://questionsmedicales.fr/mesh/D001479?mesh_terms=Implementation+Science&page=6#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Noyaux gris centraux", "description": "Quels sont les symptômes courants des troubles des noyaux gris centraux ?\nComment se manifestent les troubles de la coordination ?\nLes troubles de la parole sont-ils liés aux noyaux gris centraux ?\nLes changements d'humeur peuvent-ils être un symptôme ?\nQuelles sont les manifestations de la rigidité musculaire ?", "url": "https://questionsmedicales.fr/mesh/D001479?mesh_terms=Implementation+Science&page=6#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Noyaux gris centraux", "description": "Peut-on prévenir les troubles des noyaux gris centraux ?\nQuel rôle joue l'alimentation dans la prévention ?\nLe contrôle du stress peut-il aider à prévenir ces troubles ?\nL'éducation sur les symptômes est-elle importante ?\nLes activités cognitives peuvent-elles prévenir les troubles ?", "url": "https://questionsmedicales.fr/mesh/D001479?mesh_terms=Implementation+Science&page=6#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Noyaux gris centraux", "description": "Quels traitements sont disponibles pour les troubles des noyaux gris centraux ?\nLes médicaments peuvent-ils soulager les symptômes ?\nQuand la chirurgie est-elle envisagée ?\nLa thérapie physique est-elle bénéfique ?\nQuels sont les effets des thérapies complémentaires ?", "url": "https://questionsmedicales.fr/mesh/D001479?mesh_terms=Implementation+Science&page=6#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Noyaux gris centraux", "description": "Quelles complications peuvent survenir avec ces troubles ?\nLes troubles cognitifs sont-ils une complication fréquente ?\nComment les troubles de la marche peuvent-ils affecter la vie quotidienne ?\nLes complications psychologiques sont-elles possibles ?\nLes complications peuvent-elles affecter la qualité de vie ?", "url": "https://questionsmedicales.fr/mesh/D001479?mesh_terms=Implementation+Science&page=6#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Noyaux gris centraux", "description": "Quels sont les facteurs de risque pour les troubles des noyaux gris centraux ?\nLe mode de vie influence-t-il le risque ?\nLes traumatismes crâniens sont-ils un facteur de risque ?\nLes maladies auto-immunes peuvent-elles jouer un rôle ?\nL'exposition à des toxines est-elle un risque ?", "url": "https://questionsmedicales.fr/mesh/D001479?mesh_terms=Implementation+Science&page=6#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une dysfonction des noyaux gris centraux ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Un diagnostic repose sur l'examen neurologique, l'imagerie cérébrale et l'historique médical." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour évaluer les noyaux gris centraux ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Les tests incluent l'IRM, le scanner et des évaluations fonctionnelles spécifiques." } }, { "@type": "Question", "name": "Quels signes cliniques indiquent une atteinte des noyaux gris centraux ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Les signes incluent des tremblements, une rigidité musculaire et des troubles de la coordination." } }, { "@type": "Question", "name": "Les tests génétiques sont-ils utiles pour le diagnostic ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils peuvent aider à identifier des maladies héréditaires affectant les noyaux gris centraux." } }, { "@type": "Question", "name": "Quelle est l'importance de l'historique médical dans le diagnostic ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "L'historique médical aide à identifier des antécédents familiaux ou des symptômes précurseurs." } }, { "@type": "Question", "name": "Quels sont les symptômes courants des troubles des noyaux gris centraux ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent des mouvements involontaires, des troubles de l'équilibre et de la posture." } }, { "@type": "Question", "name": "Comment se manifestent les troubles de la coordination ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Ils se manifestent par des difficultés à exécuter des mouvements précis et fluides." } }, { "@type": "Question", "name": "Les troubles de la parole sont-ils liés aux noyaux gris centraux ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des troubles de la parole peuvent survenir en raison de dysfonctionnements dans ces structures." } }, { "@type": "Question", "name": "Les changements d'humeur peuvent-ils être un symptôme ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des changements d'humeur et des troubles cognitifs peuvent être associés à ces troubles." } }, { "@type": "Question", "name": "Quelles sont les manifestations de la rigidité musculaire ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "La rigidité musculaire se traduit par une résistance accrue aux mouvements passifs des membres." } }, { "@type": "Question", "name": "Peut-on prévenir les troubles des noyaux gris centraux ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Certaines mesures de style de vie, comme l'exercice régulier, peuvent réduire les risques." } }, { "@type": "Question", "name": "Quel rôle joue l'alimentation dans la prévention ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation équilibrée riche en antioxydants peut contribuer à la santé cérébrale." } }, { "@type": "Question", "name": "Le contrôle du stress peut-il aider à prévenir ces troubles ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la gestion du stress peut réduire le risque de troubles neurologiques." } }, { "@type": "Question", "name": "L'éducation sur les symptômes est-elle importante ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une éducation précoce sur les symptômes peut favoriser un diagnostic rapide." } }, { "@type": "Question", "name": "Les activités cognitives peuvent-elles prévenir les troubles ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les activités cognitives stimulantes peuvent aider à maintenir la santé cérébrale." } }, { "@type": "Question", "name": "Quels traitements sont disponibles pour les troubles des noyaux gris centraux ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements incluent des médicaments, la thérapie physique et, dans certains cas, la chirurgie." } }, { "@type": "Question", "name": "Les médicaments peuvent-ils soulager les symptômes ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des médicaments comme les anticholinergiques et les dopaminergiques peuvent aider." } }, { "@type": "Question", "name": "Quand la chirurgie est-elle envisagée ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "La chirurgie est envisagée lorsque les traitements médicamenteux ne sont pas efficaces." } }, { "@type": "Question", "name": "La thérapie physique est-elle bénéfique ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle aide à améliorer la mobilité et à réduire les symptômes moteurs." } }, { "@type": "Question", "name": "Quels sont les effets des thérapies complémentaires ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Les thérapies complémentaires peuvent aider à gérer le stress et améliorer le bien-être général." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec ces troubles ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent des chutes, des blessures et des troubles de la déglutition." } }, { "@type": "Question", "name": "Les troubles cognitifs sont-ils une complication fréquente ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des troubles cognitifs peuvent survenir, affectant la mémoire et la concentration." } }, { "@type": "Question", "name": "Comment les troubles de la marche peuvent-ils affecter la vie quotidienne ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Ils peuvent limiter l'autonomie et augmenter le risque de chutes et d'accidents." } }, { "@type": "Question", "name": "Les complications psychologiques sont-elles possibles ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des complications comme l'anxiété et la dépression peuvent survenir." } }, { "@type": "Question", "name": "Les complications peuvent-elles affecter la qualité de vie ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles peuvent réduire la qualité de vie en limitant les activités quotidiennes." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque pour les troubles des noyaux gris centraux ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent l'âge, des antécédents familiaux et certaines maladies neurologiques." } }, { "@type": "Question", "name": "Le mode de vie influence-t-il le risque ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un mode de vie sédentaire et une mauvaise alimentation augmentent le risque." } }, { "@type": "Question", "name": "Les traumatismes crâniens sont-ils un facteur de risque ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les traumatismes crâniens peuvent augmenter le risque de troubles neurologiques." } }, { "@type": "Question", "name": "Les maladies auto-immunes peuvent-elles jouer un rôle ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines maladies auto-immunes peuvent affecter les noyaux gris centraux." } }, { "@type": "Question", "name": "L'exposition à des toxines est-elle un risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'exposition à certaines toxines environnementales peut augmenter le risque." } } ] } ] }

Sources (10000 au total)

Advancing health equity through implementation science: Identifying and examining measures of the outer setting.

Implementation science (IS) could accelerate progress toward achieving health equity goals. However, the lack of attention to the outer setting where interventions are implemented limits applicability... To describe the development of the Outer Setting Data Resource and characterize the county-level outer context across Centers.... Our Data Resource captures seven key environments, including: (1) food; (2) physical; (3) economic; (4) social; (5) health care; (6) cancer behavioral and screening; and (7) cancer-related policy. Dat... ISC... Our results indicate that the outer setting varies across Centers and often differs from the national level. These findings demonstrate the importance of assessing the contextual environment in which ...

Implementation Science and Pediatric Diabetes: A Scoping Review of the State of the Literature and Recommendations for Future Research.

This scoping review aimed to identify implementation science (IS) research in pediatric diabetes, report integration of IS theory and terminology, and offer guidance for future research.... Of 23 papers identified, 19 were published since 2017 and 21 focused on type 1 diabetes. Most involved medical evidence-based practices (EBPs; n = 15), whereas fewer focused on psychosocial (n = 7) an...

Economic evaluation of implementation science outcomes in low- and middle-income countries: a scoping review.

Historically, the focus of cost-effectiveness analyses has been on the costs to operate and deliver interventions after their initial design and launch. The costs related to design and implementation ... We searched Web of Science and PubMed for papers published between January 1, 2010, and December 31, 2021, that included components of both implementation science and economic evaluation. Studies from... Six thousand nine hundred eighty-six studies were screened, of which 55 were included in full-text review and 23 selected for inclusion and data extraction. Most papers were theoretical, though some f... A sparse but growing literature explores the intersection of implementation science and economic evaluation. Key needs include more research in LMICs, greater consensus on the definition of implementa... The protocol for this manuscript was published on the Open Science Framework. It is available at: https://osf.io/ms5fa/ (DOI: 10.17605/OSF.IO/32EPJ)....

Implementation of prediction models in the emergency department from an implementation science perspective-Determinants, outcomes and real-world impact: A scoping review protocol.

The number of prediction models developed for use in emergency departments (EDs) have been increasing in recent years to complement traditional triage systems. However, most of these models have only ...

Generative AI in healthcare: an implementation science informed translational path on application, integration and governance.

Artificial intelligence (AI), particularly generative AI, has emerged as a transformative tool in healthcare, with the potential to revolutionize clinical decision-making and improve health outcomes. ... This article aims to provide a comprehensive overview of the use of generative AI in healthcare, focusing on the utility of the technology in healthcare and its translational application highlighting ... Generative AI has the potential to transform healthcare through automated systems, enhanced clinical decision-making and democratization of expertise with diagnostic support tools providing timely, pe... It is strongly argued in this article that generative AI can usher in tremendous healthcare progress, if introduced responsibly. Strategic adoption based on implementation science, incremental deploym...

Using implementation science frameworks to translate and adapt a pregnancy app for an emerging Latino community.

Digital mobile health (mHealth) applications are a popular form of prenatal education and care delivery in the U.S.; yet there are few Spanish language options for native speakers. Furthermore, existi... To adapt and translate an English-language pregnancy mobile health app to meet the language and cultural needs of Spanish-speaking Latino immigrants living in the United States.... We use a multi-step process, grounded in implementation science frameworks, to adapt and translate the contents of an existing pregnancy app. Interviews with stakeholders (n = 12) who advocate for the... The interviews with stakeholders revealed seven critical domains that need to be addressed in an adapted prenatal app: language and communication, financial concerns, social support, immigration statu... This work illustrates a process to adapt an mHealth pregnancy app to the needs of an emerging Latino community, by incorporating culturally sensitive Spanish language content while focusing on address...

Reducing Ileostomy Readmissions: Using Implementation Science to Evaluate the Adoption of a Quality Improvement Initiative.

Translating empirical evidence into clinical practice remains challenging. Prevention of morbidity from new ileostomies may serve as an example. Despite evidence demonstrating improvements in electrol... We used the Reach, Effectiveness, Adoption, Implementation, and Maintenance implementation science framework to identify barriers and facilitators in the adoption of a quality improvement initiative a... Qualitative interviews were conducted with stakeholders based on the domains of the Reach, Effectiveness, Adoption, Implementation, and Maintenance framework.... Participating community and academic hospitals across Michigan (n = 12).... Convenience sampling was used to recruit 25 key stakeholders, including wound, ostomy, and continence nurses; registered nurses; nurse practitioners; nurse managers; colorectal surgeons; surgery resid... Through qualitative content analysis, we located, analyzed, and identified patterns using the Reach, Effectiveness, Adoption, Implementation, and Maintenance framework.... We identified the following factors to increase the adoption of quality improvement initiatives at the provider level: 1) selection and coaching of champions, 2) broadening of multidisciplinary teams,... Limited to high-volume ileostomy surgery hospitals, did not include in-person site visits to each hospital before and after implementation, and did not consider the hospital- and patient-level factors... Integrating implementation science frameworks to rigorously study quality improvement initiatives may reveal the determinants of the widespread adoption of evidence-based practices.... ANTECEDENTES:Traducir la evidencia empírica a la práctica clínica sigue siendo un desafío. La prevención de la morbilidad por nuevas ileostomías puede servir como ejemplo. A pesar de la evidencia que ...

Increasing Uptake of Depression Screening and Treatment Guidelines in Cardiac Patients: A Behavioral and Implementation Science Approach to Developing a Theory-Informed, Multilevel Implementation Strategy.

Depression leads to poor health outcomes in patients with coronary heart disease (CHD). Despite guidelines recommending screening and treatment of depressed patients with CHD, few patients receive opt... We conducted a narrative review of barriers to depression screening and treatment in patients with CHD (ie, medications, exercise, cardiac rehabilitation, or therapy) comprising data from 748 study pa... We identified implementation barriers at the system/provider level (eg, Capability: knowledge; Opportunity: workflow integration; Motivation: ownership) and patient level (eg, Capability: knowledge; O... We applied implementation and behavioral science methods to identify implementation barriers and to develop a multilevel implementation strategy for increasing uptake of depression screening and treat...

Integrating Implementation Science in a Quality and Patient Safety Improvement Learning Collaborative: Essential Ingredients and Impact.

There is a current lack of research exploring the contextual factors of why and how quality improvement collaboratives (QICs) work. To this end, a mixed methods study was undertaken to improve our und... The authors used a mixed methods approach consisting of a written survey and 30-to-45-minute telephone interviews with collaborative team members, coaches, and senior leaders of participating safety i... Four themes emerged as the essential elements: (1) integrating implementation science into the QI/patient safety learning collaborative; (2) reinforcing of and opening eyes to implementation science b... This study's findings provide deeper insight into the "essential ingredients" (expert implementation specialist, coaches) grounded in an integrated approach that drew from QI, patient safety, and impl...